- Home
- OPP vs TNYA Comparison
OPP vs TNYA Comparison
Compare OPP & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
HOLD
Current Price
$0.68
Company Overview
Basic Information| Metric | OPP | TNYA |
|---|---|---|
| Founded | 2010 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 204.0M | 234.8M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | OPP | TNYA |
|---|---|---|
| Price | $7.83 | $0.68 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 108.0K | ★ 6.4M |
| Earning Date | 01-01-0001 | 11-10-2025 |
| Dividend Yield | ★ 14.41% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.26 | $0.36 |
| 52 Week High | $8.83 | $2.35 |
Technical Indicators
Market Signals| Indicator | OPP | TNYA |
|---|---|---|
| Relative Strength Index (RSI) | 37.04 | 25.29 |
| Support Level | $7.94 | $0.79 |
| Resistance Level | $8.03 | $1.46 |
| Average True Range (ATR) | 0.07 | 0.10 |
| MACD | -0.01 | -0.07 |
| Stochastic Oscillator | 25.00 | 2.12 |
Price Performance
Historical Comparison OPP
TNYA
About OPP RiverNorth/DoubleLine Strategic Opportunity Fund Inc.
RiverNorth/DoubleLine Strategic Opportunity Fund Inc is a closed-end management investment company. The company's investment objective is to seek current income and overall total return.
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.